Procter & Gamble Health Balance Sheet
- Market cap
- ₹8,667 crore
- P/E
- 24.3
- P/B
- 16.52
- ROE
- 61.5%
- Dividend yield
- 1.72%
As of Mar 2022, Procter & Gamble Health had total assets of ₹888 crore and borrowings of ₹2.83 crore, against shareholders' equity of ₹254 crore — a debt-to-equity ratio of 0.01. Borrowings fell 76.42% from Mar 2023.
Procter & Gamble Health balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 16.6 | 16.6 | 16.6 | 500 | 16.6 |
| Reserves | 237 | 371 | 158 | 8,500 | 147 |
| Borrowings | 2.83 | 12 | 9.56 | 1,200 | 9.29 |
| Other liabilities | 269 | 338 | 247 | 3,500 | 308 |
| Total liabilities | 888 | 1,101 | 794 | 13,700 | 841 |
| Fixed assets | 150 | 173 | 132 | 6,500 | 113 |
| Capital work in progress | 100 | 100 | 100 | 400 | 100 |
| Investments | 178 | 220 | 159 | 2,500 | 168 |
| Other assets | 266 | 330 | 238 | 4,300 | 252 |
| Total assets | 888 | 1,101 | 794 | 13,700 | 841 |
Balance sheet ratios
- Debt to equity
- 0.01
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Procter & Gamble Health balance sheet — frequently asked questions
What is the total debt of Procter & Gamble Health?
Procter & Gamble Health reported borrowings of ₹2.83 crore as of Mar 2022, compared with ₹12 crore as of Mar 2023.
What is Procter & Gamble Health's debt-to-equity ratio?
Based on the Mar 2022 balance sheet, Procter & Gamble Health's debt-to-equity ratio is 0.01 — borrowings of ₹2.83 crore against equity capital and reserves of ₹254 crore.
What are Procter & Gamble Health's total assets?
Procter & Gamble Health's total assets were ₹888 crore as of Mar 2022, including fixed assets of ₹150 crore and investments of ₹178 crore.
Same Data For Peers
Trade Procter & Gamble Health With ATS
Track PGHL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.